Evidence map›Paper›PMID 21828281›Full record

ArticleJournal of cardiovascular pharmacology and therapeutics2012

All preconditioning-related G protein-coupled receptors can be demonstrated in the rabbit cardiomyocyte.

Wenkuan Xin, Xiulan Yang, Thomas C Rich, Thomas Krieg, Robert Barrington, Michael V Cohen, James M Downey

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiovascular pharmacology and therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. APurinergic signalling · 2025
    Review
  3. Ion Channel-Based Reporters for cAMP Detection.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wenkuan XinDepartment of Pharmacology, University of South Alabama College of Medicine, Mobile, AL 36688, USA.
Xiulan Yang
Thomas C Rich
Thomas Krieg
Robert Barrington
Michael V Cohen
James M Downey
University of South Alabama · USUniversity of Cambridge · GB

Funding

PHYSICAL FACTORS AND CORONARY FLOWR01HL020648 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI DOWNEY, JAMES M · 1985 to 2011
$2.7M
Cyclic AMP signaling in cardiac myocytesR01HL074278 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI RICH, THOMAS C · 2004 to 2007
$1.1M
NHLBI NIH HHS HL-20468NHLBI NIH HHS HL-74278NHLBI NIH HHS R01 HL020648NHLBI NIH HHS R01 HL074278
6 · The paper itself

Abstract

G protein-coupled receptors for adenosine (A(1), A(3), A(2A), and A(2B)), bradykinin (B(1)) and opioids (δ) are all involved in the mechanism of ischemic preconditioning. Although the heart is comprised of many tissue types, it has been assumed that preconditioning's protective signaling occurs in the cardiomyocyte. We critically tested that hypothesis by testing for the presence of each of these receptors in isolated adult rabbit ventricular myocytes that had been transfected with cyclic nucleotide-gated (CNG) ion channels. Because subsarcolemmal cyclic adenosine monophosphate (cAMP) opens the CNG channels, we could monitor cAMP levels within a single cardiomyocyte by measuring channel current with a patch pipette. The presence of a receptor would be confirmed if we could alter cAMP in the cell with a selective agonist to the receptor being studied. Superfusion with the β-adrenergic G(s)-coupled receptor agonist isoproterenol (50 nmol/L) transiently increased cAMP levels and, therefore, channel current. Pretreatment with selective agonists to A(1) or A(3) adenosine receptors (ARs) that are G(i)-coupled markedly attenuated the response to isoproterenol, indicating inhibition of adenylyl cyclase by increased G(i) activity. Agonists to bradykinin or δ-opioid receptors also attenuated isoproterenol's response. A(2A)AR and A(2B)AR are G(s)-coupled. The A(2A)AR-selective agonist CGS21680 increased current through CNG channels but only in the presence of phosphodiesterase (PDE) inhibitors, indicating low surface receptor activity and high intracellular PDE activity. As we previously reported, BAY 60-6583, an A(2B)AR-selective agonist which mimics preconditioning's protection in rabbit heart, neither increased nor decreased membrane current in transfected cardiomyocytes, suggesting the absence or a markedly limited number of A(2B)AR in the sarcolemma. However, reverse transcription polymerase chain reaction (RT-PCR) of purified cardiomyocytes yielded an A(2B)AR band, implying that rabbit cardiomyocytes do indeed express A(2B)AR. These data reveal that all receptors reported to be involved in ischemic preconditioning do exist on or within the cardiomyocyte.

Indexed as

AnimalsCyclic AMPCyclic Nucleotide-Gated Cation ChannelsFemaleHeart VentriclesIschemic PreconditioningIsoproterenolMaleMyocytes, CardiacPurinergic P1 Receptor AgonistsRabbitsReceptor, Bradykinin B1Receptors, Opioid, deltaReceptors, Purinergic P1Reverse Transcriptase Polymerase Chain ReactionSarcolemmaCyclic AMPCyclic Nucleotide-Gated Cation ChannelsIsoproterenolPurinergic P1 Receptor AgonistsReceptor, Bradykinin B1Receptors, Opioid, deltaReceptors, Purinergic P1

Identifiers

PMID21828281
PMCPMC3533434
OpenAlexW2130355422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.